Repositório Científico do Instituto Nacional de Saúde >
Departamento de Doenças Infecciosas >
DDI - Posters/abstracts em congressos internacionais >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10400.18/749

Título: Deletion analysis on multidrug resistant Mycobacterium tuberculosis in Portugal
Autor: Silva, Carla
Perdigão, João
Couto, Isabel
Viveiros, Miguel
Jordão, Luísa
Portugal, Isabel
Palavras-chave: Mycobacterium Tuberculosis
MDR
Infecções Respiratórias
Issue Date: 2011
Editora: Instituto Nacional de Saúde Doutor Ricardo Jorge, IP
Resumo: Deletion analysis on multidrug-resistant Mycobacterium tuberculosis in Portugal Carla Silva1,4, João Perdigão1, Isabel Couto2,3, Miguel Viveiros2,5, Luísa Jordão4 and Isabel Portugal1 1URIA, Centro de Patogénese Molecular, Faculdade de Farmácia da Universidade de Lisboa, 2Unit of Mycobacteriology, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (IHMT/UNL), 3Centro de Recursos Microbiológicos (CREM), Faculdade de Ciências e Tecnologia, 4Departamento de Doenças Infecciosas, Instituto Nacional de Saúde Dr Ricardo Jorge, 5COST ACTION BM0701 (ATENS) Portugal is one of the European countries with the highest incidence of tuberculosis (TB), with a notification rate higher than 20/100 000 inhabitants. One of the biggest threats to TB control is the emergence of infection case with features of multidrug resistance (MDR-TB) and extensive drug-resistance (XDR-TB) TB. Most strains of MDR-TB circulating in the Lisbon area belong to a particular family of genetically related strains, the Lisboa family, detected in the 90’s. The prevalence of this family of strains has increased over the years, and represented more than 85% of the MDR-TB strains in the year of 2008. XDR-TB has been recently derived from MDR-TB strains and account for about 50% of these, the majority belonging to Lisboa family. Lisboa family represent a serious problem regarding TB control in Portugal and its prevalence in recent years suggests that these strains may have selective advantages over others. In an attempt to define the evolutionary origin and the identification of factors that favors the continued existence and spread of Lisboa strains in the Portuguese setting, genomic deletions in seven MDR-TB clinical isolates representative of the principal clusters circulating in Portugal were studied. Previously characterized by 24 loci MIRU-VNTR, the isolates were analyzed for the presence or absence of the genomic regions pks15/1, RD105 and RD174. We verified that five of the 7 isolates analyzed belong to the Euro American Lineage, with the 7bp deletion on pks15/1 gene, with other two belonging to the East-Asia Lineage (including the Beijing family strains), characterized by the presence of an intact pks15/1 gene and absence of RD105 region. Further analysis of the Euro American Lineage strains revealed that four strains, including the two representative strains of Lisboa family, present the same second genomic deletion – RD174, a marker for the sublineage West Africa; the remaining isolate is still under study, and more analysis are ongoing. We conclude that the circulating strains present some lineage diversity, with the predominant strains, Lisboa family, belonging to the West Africa Sublineage. Such, may be indicative of selective advantages and/or better adaptation to the host population in the presence of circulating Beijing strains.
Arbitragem científica: yes
URI: http://hdl.handle.net/10400.18/749
Appears in Collections:DDI - Posters/abstracts em congressos internacionais

Files in This Item:

File Description SizeFormat
Abstract_ESM_2011.pdf563,64 kBAdobe PDFView/Open
Restrict Access. You can request a copy!
Statistics
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  © 2010 www.insa.pt - Todos os direitos reservados | Feedback Ministério da Saúde

Estamos no RCAAP Governo Português separator Ministério da Educação e Ciência  Fundação para a Ciência e a Tecnologia

Financiado por:

POS_C UE